Startup profile · funding coverage
FAZE Security funding, valuation and investors
Agentic offensive-security orchestration that continuously tests web apps, APIs, and cloud environments and retests until exploits fail.
Verified company research · funding, investors and latest developments
Keep track of FAZE Security
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Seed
$6M · September 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$6M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
seed · Israel / United States
Investors in latest funding
Lead: New Era Capital Partners
Other: Lockstep VC
Overview
FAZE Security (formerly CYTRIX) builds an Offensive Security Orchestration platform centered on an Agentic Red Team: autonomous agents trained on proprietary attack data that attempt to exploit exposures, rank findings by demonstrated business impact, assign owners, and retest until exploits fail.
On September 11, 2026 the company announced a $6 million seed led by New Era Capital Partners with Lockstep VC, alongside company claims of 50 enterprise customers (including Fortune 500 names) and roughly 20-fold ARR growth over 18 months.
Why FAZE Security is interesting
Emerged from stealth (ex-CYTRIX) with a $6M New Era–led seed on Sep 11, 2026 already claiming 50 enterprise customers and ~20× ARR growth — seed-stage check size with Series A-looking proof, if the metrics hold.
Product & use cases
Continuous agentic red-team testing across web, API, and cloud surfaces with exploit proof, ownership, remediation paths, and automated retest loops.
- Replace or augment point-in-time pen tests with continuous offensive coverage
- Prioritize vulnerabilities by demonstrated exploitability and business impact
- Verify remediations automatically until exploits no longer succeed
Key facts
- $6M seed led by New Era Capital Partners with Lockstep VC (Sep 11, 2026)
- Company: 50 enterprise customers; ~20× ARR growth in 18 months (company-claimed)
- Formerly CYTRIX; customers report ~0 false positives and >50% faster MTTR vs scanners/pen tests (company-claimed)
Funding history (newest first)
Seed
2026-09 $6M- New Era Capital Partners (lead)
- Lockstep VC (participant)
Source: Read source · prnewswire.com
Market / IPO context
Editorial / static context — not a live quote.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.